US Democrats fighting insulin prices might falter as midterms near

The upcoming midterm elections in the US could throw a wrench into Democrats’ plans to cap diabetes patients’ out-of-pocket insulin expenses.
Photo: George Frey/Reuters/Ritzau Scanpix
Photo: George Frey/Reuters/Ritzau Scanpix
by christian bundgaard, translated by daniel pedersen

Bipartisan support is needed before the US can secure more affordable insulin for diabetes patients, and bipartisan support is becoming more unlikely as November’s midterm elections in the US come closer, reports Reuters.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading